Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias P Wymann

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Cell|August 6, 2004
PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effectsEnrico Patrucco, Antonella Notte, Laura Barberis, et al.
Journal of Medicinal Chemistry|June 28, 2019
(<i>S</i>)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR KinaseDenise Rageot, Thomas Bohnacker, Erhan Keles, et al.
Cardiovascular Research|December 21, 2013
Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathwayStephanie Gayral, Roselyne Garnotel, Audrey Castaing-Berthou, et al.
Neuropharmacology|September 5, 2020
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complexWiebke Theilmann, Birthe Gericke, Alina Schidlitzki, et al.
Nature Chemical Biology|February 6, 2019
A class of highly selective inhibitors bind to an active state of PI3KγGangadhara Gangadhara, Göran Dahl, Thomas Bohnacker, et al.
Neuron|May 27, 2003
Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neuronsHeng-Ye Man, Qinhua Wang, Wei-Yang Lu, et al.
Journal of Medicinal Chemistry|August 23, 2017
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in OncologyFlorent Beaufils, Natasa Cmiljanovic, Vladimir Cmiljanovic, et al.
EMBO Reports|July 7, 2026
A conserved VPS34-PIKfyve-TRPML1-myosin II axis regulates the speed of amoeboid cell migrationPhilippe Dehio, Céline Michard, Juan Carlos Yam-Puc, et al.
Nature Medicine|August 30, 2005
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritisMontserrat Camps, Thomas Rückle, Hong Ji, et al.
Blood|May 10, 2005
Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophilsAlison M Condliffe, Keith Davidson, Karen E Anderson, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Cell|August 6, 2004
PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effectsEnrico Patrucco, Antonella Notte, Laura Barberis, et al.
Journal of Medicinal Chemistry|June 28, 2019
(<i>S</i>)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR KinaseDenise Rageot, Thomas Bohnacker, Erhan Keles, et al.
Cardiovascular Research|December 21, 2013
Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathwayStephanie Gayral, Roselyne Garnotel, Audrey Castaing-Berthou, et al.
Neuropharmacology|September 5, 2020
Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complexWiebke Theilmann, Birthe Gericke, Alina Schidlitzki, et al.
Nature Chemical Biology|February 6, 2019
A class of highly selective inhibitors bind to an active state of PI3KγGangadhara Gangadhara, Göran Dahl, Thomas Bohnacker, et al.
Neuron|May 27, 2003
Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neuronsHeng-Ye Man, Qinhua Wang, Wei-Yang Lu, et al.
Journal of Medicinal Chemistry|August 23, 2017
5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in OncologyFlorent Beaufils, Natasa Cmiljanovic, Vladimir Cmiljanovic, et al.
EMBO Reports|July 7, 2026
A conserved VPS34-PIKfyve-TRPML1-myosin II axis regulates the speed of amoeboid cell migrationPhilippe Dehio, Céline Michard, Juan Carlos Yam-Puc, et al.
Nature Medicine|August 30, 2005
Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritisMontserrat Camps, Thomas Rückle, Hong Ji, et al.
Blood|May 10, 2005
Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophilsAlison M Condliffe, Keith Davidson, Karen E Anderson, et al.
Pageof 8